M05.0 Felty's syndrome

Name of the Condition

• Felty's syndrome (ICD-10: M05.0)

Summary

Felty's syndrome is a rare complication of rheumatoid arthritis characterized by the triad of rheumatoid arthritis, splenomegaly (enlarged spleen), and neutropenia (low neutrophil count). It typically occurs in individuals with long-standing, severe rheumatoid arthritis and is associated with increased susceptibility to infections due to neutropenia.

Causes

Felty's syndrome is considered a variant of rheumatoid arthritis, though its exact cause is not fully understood. It is thought to result from chronic inflammation and immune dysregulation, leading to splenic sequestration of neutrophils and bone marrow suppression. The condition is strongly associated with high titers of rheumatoid factor and anti-citrullinated protein antibodies (ACPA).

Risk Factors

• Long-standing, severe rheumatoid arthritis
• High titers of rheumatoid factor
• Presence of anti-citrullinated protein antibodies (ACPA)
• Advanced age (typically over 50 years)
• Female gender (more commonly affected)

Symptoms

• Persistent joint pain, swelling, and stiffness from underlying rheumatoid arthritis
• Fatigue and weakness
• Recurrent infections due to neutropenia
• Abdominal discomfort or fullness from splenomegaly
• Unexplained weight loss
• Skin discoloration or ulcers (less common)

Diagnosis

Diagnosis of Felty's syndrome requires confirmation of the triad: rheumatoid arthritis, splenomegaly, and neutropenia. Laboratory tests include complete blood count (CBC) to assess neutrophil levels, rheumatoid factor and ACPA testing, and imaging (e.g., ultrasound or CT) to evaluate splenic size. Bone marrow biopsy may be performed to rule out other causes of neutropenia.

Treatment Options

Treatment focuses on managing rheumatoid arthritis and addressing neutropenia. Options include disease-modifying antirheumatic drugs (DMARDs) to control joint inflammation, granulocyte colony-stimulating factor (G-CSF) to increase neutrophil counts, and antibiotics for infections. Splenectomy may be considered in severe cases, though it is rarely performed due to risks.

Prognosis and Follow-Up

Prognosis depends on the severity of neutropenia and infection risk. Regular monitoring of blood counts, joint status, and infection signs is essential. Early intervention can improve outcomes, but the condition may progress if underlying rheumatoid arthritis is uncontrolled. Lifelong follow-up with a rheumatologist is recommended.

Complications

• Severe or recurrent infections due to neutropenia
• Increased risk of lymphoma (associated with long-standing rheumatoid arthritis)
• Splenic rupture (rare)
• Worsening joint damage from uncontrolled rheumatoid arthritis

Lifestyle & Prevention

• Maintain good hygiene to reduce infection risk
• Follow prescribed rheumatoid arthritis treatment to control inflammation
• Avoid smoking, which may exacerbate rheumatoid arthritis
• Report any signs of infection (e.g., fever, sore throat) promptly

When to Seek Professional Help

Seek immediate medical attention if you experience:

• Fever or chills
• Unexplained bruising or bleeding
• Severe abdominal pain
• Rapid onset of joint swelling or pain
• Persistent fatigue or weakness

Tips for Medical Coders

When coding Felty's syndrome, ensure documentation confirms the presence of rheumatoid arthritis, splenomegaly, and neutropenia. Code M05.0 is specific to Felty's syndrome and should not be used if these components are not documented. Verify that the diagnosis aligns with the clinical criteria to avoid miscoding.